$20 off your first month Identify & address the underlying causes of chronic health conditions
JOIN NOW

Already have an account?

Article

Harnessing the Power of Non-Pharmaceutical Interventions for Parkinson’s Disease

Saturday, July 27th 2024 10:00am 3 min read
Dr. Jessica Peatross dr.jess.md @drjessmd

Hospitalist & top functional MD who gets to the root cause. Stealth infection & environmental toxicity keynote speaker.

Parkinson’s Disease (PD) is a neurodegenerative disorder that affects millions of people worldwide. While pharmaceutical interventions have been the primary focus of treatment, there is growing interest in non-pharmaceutical interventions as complementary or alternative approaches. This article aims to explore the potential benefits of non-pharmaceutical interventions for PD, including Coenzyme Q10, Mucuna pruriens (Velvet Beans), Omega-3 Fatty Acids, and Curcumin.

1. Coenzyme Q10 (CoQ10)

Coenzyme Q10 is a naturally occurring compound that plays a crucial role in mitochondrial function and energy production. Studies have shown that CoQ10 levels are significantly lower in individuals with PD compared to healthy controls. Several clinical trials have investigated the potential benefits of CoQ10 supplementation in PD patients.

In a randomized, double-blind, placebo-controlled trial, 80 PD patients received either CoQ10 (300 mg/day) or placebo for 16 months. The results showed a significant improvement in motor function and a slower rate of functional decline in the CoQ10 group compared to the placebo group (Shults et al., 2002). Another study found that CoQ10 supplementation (1200 mg/day) led to a significant reduction in the Unified Parkinson’s Disease Rating Scale (UPDRS) score, a measure of PD severity, after 12 months (Beal et al., 2003).

2. Mucuna pruriens (Velvet Beans)

Mucuna pruriens is a legume that contains high levels of levodopa (L-DOPA), a precursor to dopamine, the neurotransmitter that is deficient in PD. Several studies have investigated the potential benefits of Mucuna pruriens in PD.

In a randomized, controlled trial, 60 PD patients received either Mucuna pruriens (200 mg of levodopa equivalent) or standard levodopa therapy for 12 weeks. The results showed that Mucuna pruriens was as effective as standard levodopa therapy in improving motor symptoms, with fewer side effects (Katzenschlager et al., 2004). Another study found that Mucuna pruriens led to a significant improvement in motor function and quality of life in PD patients (Nagashayana et al., 2000).

Members Only Content

To continue reading please subscribe to WellnessPlus by Dr. Jess MD

Be your own best doctor with our comprehensive suite of online health coaching tools.

MENU

JOIN NOW

$20 off your first month

Identify & address the underlying causes of chronic health conditions

JOIN NOW